Related references
Note: Only part of the references are listed.Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults >= 50 years of age
Susan J. Ermlich et al.
VACCINE (2018)
Direct and Indirect Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine Against Carriage in a Cluster Randomized Trial
Arto A. Palmu et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
Gerhard Falkenhorst et al.
PLOS ONE (2017)
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
Angela Dominguez et al.
PLOS ONE (2017)
Management of Bacteriuria in Veterans Affairs Hospitals
Emily S. Spivak et al.
CLINICAL INFECTIOUS DISEASES (2017)
Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
Ilias Galanis et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Impact of pneumococcal vaccination in children on serotype distribution in adult community-acquired pneumonia using the serotype-specific multiplex urinary antigen detection assay
Mathias W. Pletz et al.
VACCINE (2016)
Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012-2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes
Andreia N. Horacio et al.
FRONTIERS IN MICROBIOLOGY (2016)
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland
Timo Vesikari et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2016)
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
Chamira Rodrigo et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Pauline A. Waight et al.
LANCET INFECTIOUS DISEASES (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine
Ajoke Sobanjo-ter Meulen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia
Ankita P. Desai et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States
Sandra S. Richter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
F. Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2014)
Pneumococcal infection in adults: burden of disease
J. J. C. Drijkoningen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis
Lone Simonsen et al.
LANCET RESPIRATORY MEDICINE (2014)
Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults
Haley J. Morrill et al.
INFECTIOUS DISEASES AND THERAPY (2014)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012
Walter H. B. Demczuk et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2013)
Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged ≥50 Years With Community-Acquired Pneumonia
Robert L. Sherwin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A. Palmu et al.
LANCET (2013)
US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Marie R. Griffin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
Sheldon L. Kaplan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
Daniel R. Feikin et al.
PLOS MEDICINE (2013)
Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe
David S. Fedson et al.
EXPERT REVIEW OF VACCINES (2011)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease
Inci Yildirim et al.
VACCINE (2010)
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
Takaya Maruyama et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Optimization and Validation of a Multiplex, Electrochemiluminescence-Based Detection Assay for the Quantitation of Immunoglobulin G Serotype-Specific Antipneumococcal Antibodies in Human Serum
Rocio D. Marchese et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case-control study
Angel Vila-Corcoles et al.
VACCINE (2009)
Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies
Robert L. Burton et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults
MH Kyaw et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Pneumonia in the very old
JP Janssens et al.
LANCET INFECTIOUS DISEASES (2004)
Transmission of West Nile virus through blood transfusion in the United States in 2002
LN Pealer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy
M Pavia et al.
PUBLIC HEALTH (2003)
Effectiveness of pneumococcal polysaccharide vaccine in older adults
LA Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
S Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Share Paper
